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Abstract
Cancer is characterized by defects in the cell cycle, the program cells use to replicate and divide.
One important factor controlling the cell cycle is a protein complex known as the anaphase
promoting complex (APC/CCdh1). This complex controls the canonical cell cycle, but whether it
functions similarly in the abbreviated cell cycle, a non-canonical form of the cell cycle, is
unknown. Neural stem cells and embryonic stem cells are examples of cell types that undergo
this alternative form of the cell cycle, which is characterized by a shortened G1 phase. We
hypothesized that APC/CCdh1 is not required in the abbreviated cell cycle. To test this hypothesis,
RNAi was used to knock down expression of the C. elegans homolog of Cdh1 and
epifluorescence microscopy was used to visualize the adult hermaphrodite gonads to count the
number of germline stem cells (GSCs) that are in active cell division. We found that RNAitreated animals had significantly fewer GSCs in active cell division than the control; however,
the difference was only slight. We cannot say for certain whether our hypothesis was supported
or not, but our findings suggest that there may be a potential minor role of APC/CCdh1 in the
abbreviated cell cycle.
Introduction
The cell cycle is a series of events that takes place in a cell where DNA replication occurs
and a cell divides into two new daughter cells (Tyson and Novak, 2008). The cell cycle allows an
organism to grow, reproduce, and maintain and repair its tissues throughout life (Cooper 2000).
It is critical that progression through the cell cycle is tightly regulated in controlling DNA
replication and cell division so that the organism maintains the appropriate number of cells. One
type of inappropriate cell proliferation – having too many cells – is a fundamental characteristic
underlying all cancers, one of the leading causes of death worldwide (Collins et al., 1997). Most
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types of tumors found in humans have errors in particular transition checkpoints of the cell cycle
(Diaz-Moralli et al., 2013). By understanding more of the cell cycle’s mechanisms, we may
eventually be able to figure out ways to manipulate it for devising potential cancer treatments
and therapies.

The canonical cell cycle
The canonical cell cycle consists of four phases: G1, S, G2 and M. DNA replication
occurs during S phase, nuclear division occurs during M phase, and cell growth occurs during
gap phases called G1 and G2 (White and Dalton, 2005). In normal cells, certain requirements
must be satisfied in order for a cell to transition into the next phase of the cell cycle at the right
time and remain in each phase for the right length of time. Signals from the cell’s internal and
external environment determine if and when a cell will proceed into the next phase of the cell
cycle (Tyson and Novak, 2008). These internal and external signals affect the activity of key
cell-cycle regulators that influence a cell’s decision to continue its progression through the cycle.
This activity is called checkpoint control and there are three main checkpoints in the cell cycle:
(1) DNA-damaged induced (G1/S) checkpoint, (2) DNA-replication induced (G2/M) checkpoint,
(3) spindle-assembly checkpoint (Heuvel, 2005) (Figure 1).
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Figure 1. Canonical cell cycle phases and the main checkpoints. Figure from Cooper (2000).

The main molecules that regulate progression through the cell cycle are cyclins, cyclindependent kinases (CDKs), cyclin-dependent kinase inhibitor proteins (CKIs), and two families
of E3 ubiquitin ligases (Heuvel, 2005). At each phase, certain regulators are up-regulated while
others are down-regulated in order to move to the next phase of the cycle. CDKs, with their
corresponding cyclins, drive the progression through the cell cycle. CDK activity is regulated by
the presence of cyclins and the activity of CKIs and ubiquitin ligases. In particular, ubiquitin
ligases, enzymes that tag other proteins for degradation, are important molecules needed for cellcycle progression (Neganova and Lako, 2008). The anaphase-promoting complex/cyclosome
(APC/C), an E3 ubiquitin ligase composed of at least 11 core subunits, is one of the two
important ubiquitin ligases that regulate cell cycle transitions and is conserved from yeast to
humans (Li and Zhang, 2009). Ubiquitin-mediated proteolysis, the breakdown of proteins by
attaching ubiquitin molecules to a target protein for degradation, is the main mechanism
responsible for maintaining directionality of the cell cycle (Rizzardi and Cook, 2012). The
degradation of proteins that were required at a previous phase helps to promote an irreversible
5

commitment to the next phase of the cycle. All these components are working together and
coordinated in a specific manner in order to go through the cell cycle successfully (Figure 2).

Figure 2. Important regulators of the cell cycle. Figure from Pearson Education (2012).

In addition to being one of the two important ubiquitin ligases that regulate cell cycle
transitions, APC/C specifically coordinates the progression through and exit of mitosis into the
G1 phase and the transition from G1 to S phase (Castro et al., 2005). The activity of APC/C is
dependent on its association with an adaptor protein, cell-division cycle protein 20 (Cdc20) or
Cdc20 homologue-1 (Cdh1). Cdc20 and Cdh1 activate APC/C during early mitosis and during
late mitosis/early G1, respectively, via phosphorylation (Qiao et al., 2010). During early mitosis,
cyclin-Cdk activity is high, causing the phosphorylation of APC/C subunits, which allows the
association of Cdc20 with APC/C, denoted as APC/CCdc20 (Castro et al., 2005). As the cell
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continues into late mitosis, cyclin-Cdk activity decreases, resulting in the dephosphorylation of
APC/C subunits resulting in the dissociation of Cdc20 from APC/C. This dissociation of Cdc20
allows Cdh1 to associate with APC/C, denoted as APC/CCdh1 (Castro et al., 2005). Cdh1
association targets Cdc20 for degradation, marking the sharp and irreversible transition from
mitosis to G1 (Qiao et al., 2010). APC/CCdh1 is responsible for degrading certain mitotic cyclins
that will then decrease Cdk activity in early G1. This decrease creates proper conditions for the
assembly of pre-replicative complexes (pre-RCs) so that the cell can progress to S phase (White
and Dalton, 2005). Right before the onset of DNA replication, a certain level of early mitotic
inhibitor-1 (Emi1) protein accumulates that triggers the rapid and irreversible inactivation of
APC/CCdh1 so that other proteins needed by pre-RCs can accumulate (Cappell et al., 2016). Thus,
APC/CCdh1 is active during early G1, but must be inactivated near the end of G1 so that the cell
can carry onto S phase (Figure 3).

Figure 3. Schematic of the canonical cell cycle indicating when APC/CCdh1 is on and off. Figure
from Cappell (2016).
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The abbreviated cell cycle
The canonical cell cycle is well studied (Heuvel, 2005; Neganova and Lako, 2008; Tyson and
Novak, 2008) but knowledge on variations of this cell cycle is limited. One form of the cell cycle
of particular interest is the abbreviated cell cycle, which is characterized by a short G1 phase
(Dalton, 2015). The same sequence of phases of the canonical cell cycle comprise the
abbreviated cell cycle; however, there is a difference in the duration of certain phases. In a
typical eukaryotic somatic cell undergoing the canonical cell cycle, the G1 phase may last about
11 hours whereas in embryonic stem cells undergoing the abbreviated cell cycle, the G1 phase is
shorter and lasts about 2 hours (Cooper, 2000; Coronado et al., 2013) (Figure 4). Cells
undergoing the abbreviated cell cycle spend most (about 65%) of their time in S phase (Ballabeni
et al., 2011; Abdelalim, 2013). Another difference between the canonical and abbreviated cell
cycle is in how the cell receives signals in order to transition onto the next phase. A cell with the
canonical cell cycle (i.e., a somatic cell) monitors its environment for mitogens and other growth
factors through a G1/S transition checkpoint during the G1 phase. The cell must overcome the
G1/S restriction checkpoint in order to continue onto DNA replication and cell division.
However, cells with the abbreviated cell cycle advance through the G1/S transition in a mitogenindependent manner, which could account for a much shorter G1 period in these types of cells
(Abdelalim, 2013).
Alternative forms of the canonical cell cycle are specific to certain cell types. Induced
pluripotent stem cells, neural stem cells, and embryonic stem cells are cell types that undergo the
abbreviated cell cycle. Unearthing the components and mechanisms of the abbreviated cell cycle
could provide potential avenues for therapies and treatment of certain diseases like, for example,
cancer.
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Figure 4. Comparison of phase duration between the phases of the canonical cell cycle found in
somatic cells and the abbreviated cell cycle found in embryonic stem cells. Figure from
Abdelalim (2013).

Does APC/CCdh1play a role in the abbreviate cell cycle?
While APC/CCdh1 plays an essential role in managing the cell cycle’s proper transition
into S phase within the canonical cell cycle, it is unknown whether APC/CCdh1 functions
similarly in the abbreviated cell cycle. Knocking down Cdh1in the canonical cell cycle prompts
early onset of DNA replication and therefore decreases the duration of the G1 phase, but also
results in genome instability (Yuan et al. 2014). The G1 phase in the abbreviated cell cycle in
stem cells is significantly shorter than the G1 phase in the canonical cell cycle in somatic cells.
This difference raises the question as to how stem cells are able to proliferate and maintain
genome stability with such a short G1 phase because when a short G1 phase is artificially
induced in somatic cells, the outcome is genome instability via DNA replication stress (Macheret
and Halazonetis, 2018). This finding led us to propose the following general questions:
•

How are cell cycle transitions controlled in the abbreviated cell cycle?

•

How is the cell cycle program modified to enable the rapid passage through G1?
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Caenorhabditis elegans, an excellent model for investigating APC/CCdh1 function
An excellent system for investigating the function of APC/CCdh1 is the model organism,
Caenorhabditis elegans. The transparency of the body of C. elegans allows for easy
examination, using microscopy, of the effects of genetic manipulations on development (Joshi et
al., 2010). Furthermore, the relatively simple system of the germline of C. elegans makes for an
excellent model for investigating the role of APC/CCdh1 in the abbreviated cell cycle. The C.
elegans germline has a linear organization in which mitotically dividing germ cells, germline
stem cells (GSCs), are located at the distal end of the gonad. As the cells migrate away from the
distal region toward the proximal region, they begin the course of differentiation into gametes,
undergoing meiosis (Yuan et al., 2014). The distal region of C. elegans gonad is known as the
progenitor zone and a pool of GSCs are maintained by Notch signaling at the mesenchymal
niche comprised of a single cell called the distal tip cell (Kimble and Seidel, 2013). The cells in
this area will be the focus of our analysis in this study (Figure 5). The GSCs share many similar
features to mammalian adult stem cells and cell proliferation of the GSCs in the distal region is
maintained throughout the organism’s lifetime (Joshi et al., 2010).
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Figure 5. Illustration of C. elegans hermaphrodite gonad and the location of the progenitor zone
where the focus of our analysis took place. Figure from Seidel et al. (2018).

The C. elegans homolog of the human APC/C co-activator Cdh1 is called fizzy and cell
division cycle 20 related 1 ( fzr-1) (The et al., 2015; Medley et al., 2017). Functional disruptions
in most C. elegans genes failed to display an obvious phenotype which poses a difficulty for
scientists to assign a specific function for each gene (Hodgkin, 2001). This is the case for the
fzr-1 gene; however, more information is being gathered by examining fzr-1 and its interactions
with other genes. An example of one of those genes is lin-35/Rb, which encodes the C. elegans
ortholog of the Retinoblastoma pocket protein (pRb), which serves a redundant function as fzr-1
(Fay et al., 2002; Fay and Yochem, 2007). Given the highly conserved C-domain region and
regions of homology dispersed throughout the large N-terminal domain of APC/CFZR1/Cdh1 in
Drosophila and murine models (Fay et al., 2002), findings from the organisms in those studies
could help characterize the function of that protein in C. elegans. Studies using murine models
and human cell lines have found that fzr-1 is required for proper regulation of cyclin levels and
cell cycle progression during the canonical cell cycle, specifically during late mitosis and G1
phase (Sigl et al., 2009). In C. elegans, when fzr-1 was inactivated via RNAi microinjection, the
result was sterility suggesting a role in reproduction (Fay et al., 2002). The fzr-1 co-activator
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seems to also play a role in centrosome assembly when complexed with APC/C by acting as a
negative regulator (Medley et al., 2017). Research on the effects of fzr-1 knockdown on C.
elegans is still limited.
As previously described, in the canonical cell cycle APC/CCdh1 is essential in the proper
transition from M to G1 and G1 to S phase, but knowledge in its role in the abbreviated cell
cycle is still poorly understood. When Cdh1 was depleted in HeLa cells via siRNA, the G1 phase
was shortened. This reduction was due to the premature onset of DNA replication occurring
nearly 40% earlier compared to the control which also resulted in a prolonged S phase (Yuan et
al., 2014). This early onset and prolonged duration of S phase can make way for replication
errors and subsequent genome instability. How this information pertains to stem cells is still a
question under investigation. Stem cells showcase similar characteristics of a shortened G1 and
prolonged S phase as in Cdh1-depleted HeLa cells. Despite these similar characteristics, stem
cells don’t exhibit any errors in replication.
We hypothesize that APC/CCdh1 is not required for normal progression in the abbreviated cell
cycle. The observation that stem cells exhibit a shortened G1 phase could suggest that APC/CCdh1
is never active, that is, not expressed or always in an inactive state. Our study will examine the
germline stem cells located in the progenitor zone of hermaphrodite C. elegans gonads and the
effects the fzr-1 knockdown has on those cells. We will achieve knockdown of fzr-1 by the RNA
interference (RNAi) method and utilize a standard M-phase marker to visualize and score the
number of germline stem cells that are undergoing active mitosis. Therefore, if APC/CCdh1 is not
required for normal progression in the abbreviated cell cycle, we hypothesize that fzr-1 RNAitreated animals will display germline stem cells undergoing active mitosis in the progenitor zone.
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Materials & Methods
We performed gene knockdown of our gene of interest, fzr-1, through a process known as RNA
interference (RNAi). To carry out RNAi, we used the ‘feeding’ method with Escherichia coli
HT115 bacteria that contained our RNAi construct and subsequently introduced double-stranded
RNA to target fzr-1 for downregulation. We used T444T, a more highly efficient RNAi vector
compared to the traditional L4440 (Sturm et al., 2018), as the backbone of our vector and
inserted the fzr-1 gene into T444T to produce our RNAi construct.

C. elegans strains and maintenance
The N2 strain of Caenorhabditis elegans was used. The animals were maintained on nematode
growth media (NGM) at 15°C with E. coli OP50 as the food source. NGM contained 3 g/L NaCl,
2.5 g/L peptone, 20 g/L agar, 25 ml/L 1 M potassium phosphate buffer (1 M K2HPO4 mixed with
1 M KH2PO4 to reach a pH of 6.0), 1 mM CaCl2, 1 mM MgSO4, and 5 μg/ml cholesterol (Seidel
et al., 2018).

Construction of plasmid with the fzr-1 gene and transformation into E. coli HT115
The overall cloning strategy we performed included the following: nucleic acid purification to
isolate the vector and the fzr-1 insert, polymerase chain reaction (PCR) to amplify the vector and
fzr-1 insert, and Gibson assembly reaction to combine the vector and insert, and lastly,
transformation into bacterial cells.
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(A) Purification and PCR amplification of T444T and fzr-1
T444T was the RNAi feeding vector used for the fzr-1 gene. T444T was a gift from Tibor Vellai
(Addgene plasmid #113081; http://n2t.net/addgene:113081; RRID:Addgene_113081). The gene
of interest, fzr-1, was isolated from complementary DNA (cDNA) from the pMS9-1 plasmid
purchased from M. Song (Oakland University, Michigan). We followed the High-Yield
Supplementary Protocol in the Qiagen miniprep kit to purify the T444T vector and fzr-1 cDNA.
We amplified three fragments of DNA using PCR: the T444T vector, a long fragment of fzr-1
(1675 bp), and a short fragment of fzr-1 (575 bp). The sequences of the forward (F) and reverse
(R) primers are listed in Table 1. For the T444T vector, we used L4440 forward and reverse
primers. For the long fzr-1 fragment, we used fzr-1_exon2_F as the forward primer and fzr1_exon4_R as the reverse primer. For the short fzr-1 fragment, we used fzr-1_exon4_Fa as the
forward primer and fzr-1_exon4_R as the reverse primer (Figure 6).
Table 1. Primer sequences used for PCR amplification of the T444T vector, the long fzr-1
fragment, and the short fzr-1 fragment.
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Figure 6. Representation of the primers used during PCR and the resulting amplified regions of
fzr-1 cDNA.
The PCR mix for T444T consisted of Q5 High-Fidelity 1X Master Mix, 0.5μM L4440
forward primer, 0.5μM L4440 reverse primer, T444T (40 ng), and sterile water for a total
volume of 55 μl. The PCR conditions for T444T were as follows: initial denaturation at 98°C for
30 seconds, followed by 30 cycles of denaturation at 98°C for 10 seconds, annealing at 60°C for
15 seconds, and extension at 72°C for 1.5 minutes. The final extension was performed at 72°C
for 2 minutes. The T444T PCR product was stored at 10°C until further use. The PCR mix for
each the long and short fzr-1 fragment consisted of 1X OneTaq DNA Polymerase Master Mix,
plasmid containing fzr-1 cDNA (pMS9-1, 1 ng), 0.2 μM forward primer, 0.2 μM reverse primer,
and sterile water to bring up to a total volume of 50 μl. The PCR conditions for each the long and
short fzr-1 fragment were as follows: initial denaturation at 94°C for 2 minutes, followed by 30
cycles of: denaturation at 94°C for 30 seconds, annealing at 59°C for 45 seconds, and extension
at 68°C for 1 minute, with a final extension at 68°C for 5 minutes. The fzr-1 PCR products were
15

stored at 10°C until further use. For the analysis of all three PCR products, 1.5% agarose gels
were prepared and run for 30 minutes at constant voltage of 120V.

(B) PCR sample preparation for Gibson Assembly to generate RNAi construct
We prepared the T444T and fzr-1 PCR products by digestion and purification, respectively. The
long and short fzr-1 PCR products were each joined together with the T444T PCR product by
Gibson Assembly in order to create our RNAi vector. Prior to the Gibson Assembly, the T444T
PCR sample was digested with DpnI (20 units) in 1X CutSmart buffer. DpnI is a restriction
enzyme that only cleaves methylated DNA (NEB). This digest reduces carryover of the original
plasmid from being transformed into bacteria that could result in colonies that have the original
plasmid rather than the Gibson assembly product. We purified both fzr-1 PCR products, the long
and short fragment, by using the instructions from QIAquick PCR Purification Kit.
The Gibson reaction with the long fzr-1 fragment contained 1X Gibson Master Mix,
DpnI-treated T444T PCR product (95.2 ng), purified fzr-1 PCR product (124.02 ng), and sterile
water for a total volume of 10 μl. The Gibson reaction with the short fzr-1 fragment contained
1X Gibson Master Mix, DpnI-treated T444T PCR product (95.2 ng), purified fzr-1 PCR product
(42.96 ng), and sterile water for a total volume of 10 μl. The Gibson reactions were incubated at
50°C for 1 hour and then stored at -20°C until further use.

(C) Transformation into NEB DH5! competent E. coli Cells and purification of RNAi construct
We transformed our Gibson assembly reactions into NEB DH5! competent E. coli cells to
screen for the cells that have the recombinant DNA and to subsequently obtain a culture of them.
2 μl of Gibson reaction was added to 50 μl of NEB DH5! competent cells and incubated for 30
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minutes on ice. The cells were incubated in a 42°C water bath for 30 seconds and then
immediately placed on ice for 2 minutes. 500 μl of LB media was added to the sample and then
incubated with shaking (~230 rpm) at 37°C for 1 hour. The cells were spread onto LB plates
supplemented with ampicillin and were allowed to grow overnight at 37°C.
Single colonies were inoculated into liquid LB media supplemented with ampicillin
(100 μg/ml) and grown for 16-17 hours at 37°C with shaking. We followed the High-Yield
Supplementary Protocol in the Qiagen miniprep kit to purify the RNAi construct.

(D) Digestion of RNAi construct to confirm proper assembly
We allocated a portion of our purified sample and digested it with restriction enzyme NotI-HF to
subsequently confirm proper assembly of the construct via gel electrophoresis. The digestion
reaction consisted of 1X CutSmart buffer, our RNAi construct (~500 ng), NotI-HF (2.5 units),
and sterile water for a total volume of 30 μl. NotI-HF was expected to cut twice in our RNAi
construct (Figure 7); therefore, proper assembly is verified by the display of two bands on the
gel, one band for the T444T vector backbone and another band for the fzr-1 insert. The gel (1.5%
agarose) was prepared in 1X TAE and run at a constant voltage of 120 V for 20 minutes.

Figure 7. Visual representation of NotI-HF restriction sites on our RNAi construct.
17

(E) Transformation of RNAi construct into E. coli HT115 (DE3) strain
After we verified proper construction, we transformed the remaining purified sample into the E.
coli HT115 strain to produce the bacteria that C. elegans will feed on for the RNAi assay. CaCl2
was used to induce competency in the HT115 strain. An overnight culture of HT115 in liquid LB
media supplemented with tetracycline (10 μg/ml) was prepared. On the following day, the
overnight culture was diluted 1:100 in LB supplemented with tetracycline (10 μg/ml) then
incubated at 37°C with shaking (~210 rpm) until OD600 nm = 0.4. The sample was centrifuged
(4,800 x G) for 10 minutes at 4°C then resuspended to 0.5X original volume (OD600 nm = 0.8)
with cold, sterile 50 mM CaCl2 followed by a 30-minute incubation on ice. Our RNAi construct
(~350 ng) was added to 200 μl of CaCl2 competent HT115 and incubated on ice for 30 minutes.
The cells were incubated in 37°C water bath for 1 minute then immediately placed on ice for 2
minutes. 1 ml of LB media was added to each sample followed by an incubation period with
shaking (~210 rpm) at 37°C for 1 hour. The cells were spread onto LB plates supplemented with
ampicillin and tetracycline and were allowed to grow overnight at 37°C. The plates were stored
at 4°C until further use (Figure 8).
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Figure 8. General schematic of RNAi construct assembly and transformation into CaCl2
competent E. coli HT115 (DE3) strain. (A) Purification and PCR amplification of T444T and
fzr-1 (B) PCR sample preparation for Gibson assembly to generate RNAi construct (C)
Transformation into NEB DH5! competent E. coli cells and purification of RNAi construct (D)
Digestion of RNAi construct to confirm proper assembly (E) Transformation of RNAi construct
into E. coli HT115 (DE3) strain

Phenotype assay screening for RNAi efficacy
We performed a phenotype assay to test the efficiency of our RNAi construct on embryo
lethality. RNAi worm plates were prepared with 3 g/L NaCl, 2.5 g/L peptone, 3 g/L KH2PO4,
0.55 g/L K2HPO4, 20 g/L agar, 0.001 M MgSO4, 0.001 M CaCl2, 5 mg/ml cholesterol, 25 mg/ml
carbenicillin, and 1 M IPTG. RNAi feeder plates were seeded with the transformed RNAi
bacteria following the protocol from Anderson et al. (2008). The empty RNAi vector, L4440,
served as the negative control. The egg-5 RNAi strain served as the positive control. L4 larvae
exposure to RNAi of egg-5 inhibits the formation of the eggshell in C. elegans by blocking the
oocyte-to-embryo transition which results in embryo lethality (Zou et al., 2019). L4s were
allowed to feed for 48 hours and then a single animal was placed onto its own individual RNAi
plate seeded with the same RNAi strain as the plate they came from. The single adults were
allowed to feed for 6-8 hours then removed from each plate. The number of eggs laid was
counted. The plates were incubated overnight at 20°C, then the number of unhatched eggs was
counted (Figure 9).
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Figure 9. Schematic of phenotype assay to test the efficiency of our RNAi construct on embryo
lethality.
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Antibody staining
We dissected out C. elegans gonads and stained them with an antibody that specifically binds to
phospho-histone H3, a standard M-phase marker (Hans and Dimitrov, 2001). L4s were picked
onto NGM plates seeded with OP50, washed with M9, and transferred onto NGM plates seeded
with HT115 bacteria containing one of the RNAi constructs. The worms underwent a 48-hour
feeding period at 20°C and were then washed off the plate with 1X PBS + 0.1% Tween-20
(PBST). The worms were transferred to a glass lid containing 1X PBS + 0.1% Tween-20. The
worms were anesthetized in 0.25mM levamisole causing the animals to be paralyzed. Gonads
were dissected by decapitating the animal with a scalpel, which causes the gonads to spill out of
the body. Dissection of as many gonads as possible (~200) was completed within an 8-minute
time frame. The gonads were fixed with 3% paraformaldehyde in PBST and incubated with
rocking at room temperature for 20 minutes. Paraformaldehyde was removed and the gonads
were washed with PBST. 300 ul of -20°C methanol was added to the sample. Gonads were
incubated at -20°C for 10 minutes and washed 3 times with PBST. 3% Bovine Serum Albumin
(BSA) in PBST was added and the sample was incubated with rocking at room temperature for
20 minutes. BSA is used as a blocking agent to prohibit any non-specific binding when the
primary and secondary antibodies are added. The primary antibody, mouse anti-phospho-histone
H3 (Cell Signaling Technology, Danvers, MA, #9706), was prepared with 3% BSA in PBST at a
1:200 dilution. Incubation with the primary antibody was performed overnight with rotation at
4°C. The secondary antibody, Cy-3 donkey anti-mouse (Jackson ImmunoResearch, Westgrove,
PA, #715-165-151), was prepared with 3% BSA in PBST at a 1:100 dilution. Incubation with the
secondary antibody was performed overnight with rotation at 4°C. Gonads were mounted in
Vectashield with DAPI and stored at 4°C until use.
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Scoring of phospho-histone H3-positive (PH3+) cells
The focus of our analysis is on the cells located in the progenitor zone of the gonads of
hermaphrodite C. elegans. The primary antibody recognizes and binds to phosphorylated histone
H3 (Hans and Dimitrov, 2001). Only those cells that contain phosphorylated histone H3 are the
cells undergoing active mitosis at the time of data collection. These cells in active M-phase are
designated as PH3+ cells. We used a Nikon Y-FL Epi-Fluorescence microscope at 60x
magnification to count the number of PH3+ cells in the progenitor zone using the Texas Red
filter. DAPI staining was done to verify phospho-histone H3+ cells and to assess overall cell
morphology.

Statistical Analysis
For the RNAi phenotype assay, a X2 goodness of fit test was performed to determine if a
significant relationship existed between the different RNAi strains (control, Egg-5, long fzr-1,
short fzr-1) and the embryonic lethality phenotype (i.e. the number of eggs unhatched).
The PH3+ data were analyzed using a two-tailed T-test to determine if there was a
significant increase or decrease in the number of PH3+ cells between the control and the two
RNAi strains.
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Results
To knock down expression of fzr-1 in C. elegans, we created an RNAi feeding vector by
amplifying T444T and fzr-1 cDNA via PCR and performing a Gibson assembly reaction. T444T
was used as the vector backbone and we used two sets of primers to create two fzr-1 inserts of
different sizes, one long and one short fzr-1 fragment. To analyze our PCR products (T444T,
long fzr-1 fragment, and short fzr-1 fragment), we performed gel electrophoresis. We verified the
proper sizes of the T444T, long fzr-1 fragment, and short fzr-1 fragment PCR products to be
2469 bp, 1675 bp, and 575 bp, respectively, (Figure 10A). We performed a miniprep to isolate
the Gibson assembly of our two RNAi constructs (one containing the long fzr-1 fragment and
one with the short fzr-1 fragment) from NEB DH5! competent E. coli cells. We took a subset of
each sample and digested it with NotI-HF restriction enzyme to confirm proper assembly of the
constructs via gel electrophoresis. Each construct displayed two bands, one band for the T444T
vector backbone and the other band for the corresponding fzr-1 insert (Figure 10B). After we
verified proper construction, we transformed each of the remaining purified sample into the E.
coli HT115 strain to produce the bacteria that C. elegans will feed on for the RNAi assay. This
procedure generated two RNAi feeding vectors to knock down fzr-1, one containing a longer
fragment of the fzr-1 gene and one containing a shorter fragment of this gene.
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Figure 10. (A) Agarose gel electrophoresis of PCR products of the T444T vector (2469 bp), long
fzr-1 fragment (1675 bp), and short fzr-1 fragment (575 bp). (B) NotI-HF digestion of each
RNAi construct (lane labeled 1 containing the long fzr-1 fragment and lane labeled 2 with the
short fzr-1 fragment) to verify proper construction by displaying a two-band pattern.
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To examine the efficacy of RNAi knockdown of fzr-1, we fed L4 hermaphrodites an
RNAi strain for 48 hours and then assessed the induction of the embryo lethal phenotype by
examining the egg hatching rate. The egg-5 RNAi strain was used as the positive control and the
empty RNAi vector, L4440, served as the negative control. The expectation that the knockdown
of fzr-1 and knockdown of egg-5 would cause embryo lethality is based on previous reports (Fay
et al., 2002; Zou et al., 2019). The average percentage hatch rate of egg-5, L4440, long fzr-1
fragment, and short fzr-1 fragment were 7.7%, 99.4%, 91.4%, and 97.7%, respectively (Figure
11). We observed that treatment with the long fzr-1 RNAi feeding vector had a slight but
significantly lower percentage of hatched embryos compared to treatment with the empty vector
control. Worms treated with the short fzr-1 RNAi feeding vector showed no significant
difference of the percentage of hatched embryos compared to the control worms. RNAi treatment
with the short fzr-1 had a significantly higher percentage of hatched embryos compared to the
long fzr-1 RNAi treatment however, the difference was only slight. These results showed that the
egg-5 RNAi induced significant embryo lethality as expected, but lethality induced by
knockdown of the long fzr-1 fragment was only slight.
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Figure 11. The average percentage hatch rate of the control and the different RNAi treatments.
RNAi treatment with the long fzr-1 fragment had a slight but significantly lower percentage of
hatched embryos compared to treatment with the empty vector control. There was no significant
difference between RNAi treatment with the short fzr-1 fragment and treatment with the empty
vector control. RNAi treatment with the short fzr-1 had a significantly higher percentage of
hatched embryos compared to the long fzr-1 RNAi treatment however, the difference was only
slight. (* p < 0.05, Chi square test)
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To test whether knockdown of fzr-1 causes a cell-cycle defect in germline stem cells
(GSCs), we counted the number of GSCs in active mitosis at the distal region of gonad in C.
elegans hermaphrodites. We used an antibody that binds to a standard M-phase marker,
phospho-histone H3, to identify the cells undergoing active mitosis at the time that the animals
were dissected – designated as PH3+ cells. We could not include the images of our samples
when visualized under the fluorescent microscope in this paper. However, our images would
have closely resembled the image taken in the study from Seidel and Kimble (2015) (Figure
12A). The average number of PH3+ cells in the control (L4440), fzr-1 (long fragment) RNAi
treatment, and fzr-1 (short fragment) RNAi treatment were 5.93, 5.01, and 5.42, respectively
(Figure 12B). There was no significant difference in the number of PH3+ cells between the
control and the short fzr-1 fragment or between the two fzr-1 fragments. Animals treated with the
long fzr-1 fragment RNAi feeding vector had slightly but significantly fewer PH3+ cells than
animals treated with the empty vector control. These results showed that treatment with the fzr-1
RNAi feeding vector had only a slight effect on the cell cycle.
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Figure 12. Effect of RNAi knockdown of fzr-1 on mitosis in the germline stem cells in the C.
elegans gonad. (A) Image from Seidel and Kimble (2015) that would have resembled our images
of the distal region of an adult hermaphrodite stained with DAPI and phospho-histone H3 to
visualize M-phase GSCs. (B) The average number of PH3+ cells in the control (L4440), fzr-1
(long fragment) RNAi treatment, and fzr-1 (short fragment) RNAi treatment. There was no
significant difference in the number of PH3+ cells between the control and the short fzr-1
fragment or between the two fzr-1 fragments. Animals treated with the long fzr-1 fragment RNAi
feeding vector had slightly but significantly fewer PH3+ cells than animals treated with the
empty vector control (* p < 0.05, Chi square test).
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Discussion
APC/CCdh1 is an important regulatory molecule in the canonical cell cycle responsible for
degrading certain mitotic cyclins via ubiquitination to coordinate the transition from G1 to S
phase. The purpose of this study was to investigate the role of APC/CCdh1 in the abbreviated cell
cycle. To do this, we knocked down fzr-1, the C. elegans homolog of the human APC/C coactivator Cdh1, via RNAi and assessed the effects of knockdown on the cell cycle in germline
stem cells located at the progenitor zone of adult hermaphrodites. Germline stem cells were
analyzed because they undergo the abbreviated cell cycle. We used immunohistochemistry and
epifluorescence microscopy to visualize the number of germline stem cells undergoing active
mitosis. Our main finding was that treatment with the fzr-1 RNAi feeding vector had minimal
effect on the cell cycle as evident from the significant but only slightly fewer number of PH3+
cells in the RNAi-treated animals. Ideally, with this result, we would conclude that our
hypothesis is supported that the C. elegans homolog of APC/CCdh1 is not required for the normal
progression in the abbreviated cell cycle. However, it is impossible for us to conclusively know
this because the RNAi phenotype with respect to embryo lethality did not give us the expected
phenotype suggesting that the RNAi knockdown may have been incomplete.
We performed an experiment to assess how effective the fzr-1 RNAi treatment was in
inducing embryo lethality, a known phenotype (Fay et al., 2002). In contrast to our expectation
that RNAi treatment of fzr-1 would induce significant embryo lethality like our positive control
egg-5 (Zou et al., 2019), we found that lethality induced by RNAi knockdown of the long fzr-1
fragment was only slight. The weak phenotype that we observed suggests that our RNAi
knockdown of fzr-1 was incomplete, RNAi knockdown of fzr-1 alone could perhaps not have
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been enough to produce a strong embryo lethal phenotype, or that other genes are involved that
could compensate for the loss of function as a result from fzr-1 RNAi knockdown.
This compensation could be explained by genetic redundancy, where to two or more genes
carry out the same function (Nowak et al., 1997). Therefore, if only one of the two or more genes
was inactivated, there could be little to no effect on the phenotype. However, when redundant
genes are inactivated in certain combinations, severe defects could result in what is called a
synthetic phenotype (Fay et al., 2002). A previous study found fzr-1 to function redundantly with
a gene called lin-35/Rb, which encodes the C. elegans ortholog of the Retinoblastoma pocket
protein (pRb) (Fay et al., 2002). In that study, when fzr-1 was inactivated via RNAi injection in a
lin-35 mutant, the double mutants displayed embryo lethality and tissue hyperproliferation
whereas only low-penetrance phenotypes were seen in single mutants of fzr-1 and lin-35 (Fay et
al., 2002). There is also some evidence that fzr-1 has synthetic interactions with other genes,
specifically with a subset of class B synthetic multivulval (SynMuv) genes, which are the set of
genes that exhibit the best-known case of redundancy (Ferguson and Horvitz, 1989). The exact
mechanisms of the synthetic interactions between fzr-1 and other regulators are still largely in
question. A potential experiment in the future is to utilize combinatorial RNAi where multiple
genes can be targeted for knockdown (Tischler et al., 2006). Through this high throughput
method, we can learn more about the genetic interactions and effects of fzr-1 knockdown in
combination with knockdown of other genes in order to potentially provide a clearer
understanding on the specific functions of fzr-1.
In addition to genetic redundancy, perhaps the method of RNAi by feeding was not
sufficiently effective in silencing fzr-1. Some genes are more effectively silenced by RNAi
feeding compared to microinjection and vice versa. Other genes are equally susceptible to both

32

the feeding and microinjection method (Kamath et al., 2001). Due to time constraints, RNAi by
microinjection could not be performed in this study but is a good candidate in executing future
studies to uncover more information on fzr-1 function.
Despite our inability to establish whether or not our hypothesis was supported, our results
suggest a potential minor role of APC/CCdh1 in the abbreviated cell cycle. We hope future studies
could implement alternative methods to hopefully achieve a more definitive result. RNAi by
microinjection may be more efficient in silencing fzr-1 than RNAi by feeding. Another potential
avenue in revealing APC/CCdh1 function in the abbreviated cell cycle is to see fzr-1 knockdown
in combination with knockdown of other genes via combinatorial RNAi. Our study is a step
headed in the right direction in determining the role of APC/CCdh1 in the abbreviated cell cycle.
The more we discover about the main mediators of the abbreviated cell cycle, the more likely we
can develop techniques to control it. Those techniques may eventually be useful in treating
various diseases involved with cell cycle aberrancies, like cancer.
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